402 related articles for article (PubMed ID: 14624398)
1. Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats.
Cahová M; Vavrinková H; Tutterova M; Meschisvilli E; Kazdova L
Metabolism; 2003 Nov; 52(11):1406-12. PubMed ID: 14624398
[TBL] [Abstract][Full Text] [Related]
2. The impaired response of non-obese hereditary hypertriglyceridemic rats to glucose load is associated with low glucose storage in energy reserves.
Cahova M; Vavrinkova H; Meschisvilli E; Markova I; Kazdova L
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):549-55. PubMed ID: 15578328
[TBL] [Abstract][Full Text] [Related]
3. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
4. Defect in long-term activation of phosphatidylinositol 3-kinase by insulin in vivo: studies in insulin-resistant hHTg rats.
Sebokova E; Gasperikova D; Ouwens M; Dorrestijn J; Eckel J; Maasen A; Klimes I
Endocr Regul; 1999 Jun; 33(2):49-54. PubMed ID: 10467424
[TBL] [Abstract][Full Text] [Related]
5. Delta-6 desaturase activity and gene expression, tissue fatty acid profile and glucose turnover rate in hereditary hypertriglyceridemic rats.
Demcakova E; Sebokova ; Ukropec J; Gasperikova D; Klimes I
Endocr Regul; 2001 Dec; 35(4):179-86. PubMed ID: 11858764
[TBL] [Abstract][Full Text] [Related]
6. Different effects of IGF-I on insulin-stimulated glucose uptake in adipose tissue and skeletal muscle.
Frick F; Oscarsson J; Vikman-Adolfsson K; Ottosson M; Yoshida N; Edén S
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E729-37. PubMed ID: 10751208
[TBL] [Abstract][Full Text] [Related]
7. The effect of the new oral hypoglycemic agent A-4166 on glucose turnover in the high fat diet-induced and/or in the hereditary insulin resistance of rats.
Klimes I; Mitková A; Gasperíková D; Ukropec J; Líska B; Bohov P; Stanek J; Seböková E
Arch Physiol Biochem; 1998 Oct; 106(4):325-32. PubMed ID: 10417860
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
Oakes ND; Thalén PG; Jacinto SM; Ljung B
Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.
Henriksen EJ; Jacob S; Kinnick TR; Youngblood EB; Schmit MB; Dietze GJ
Am J Physiol; 1999 Jul; 277(1):R332-6. PubMed ID: 10409290
[TBL] [Abstract][Full Text] [Related]
10. Impaired endothelial function of thoracic aorta in hereditary hypertriglyceridemic rats.
Török J; Babál P; Matusková J; Lupták I; Klimes I; Simko F
Ann N Y Acad Sci; 2002 Jun; 967():469-75. PubMed ID: 12079876
[TBL] [Abstract][Full Text] [Related]
11. Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance.
Dal Ponte DB; Fogt DL; Jacob S; Henriksen EJ
Metabolism; 1998 Aug; 47(8):982-7. PubMed ID: 9711996
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.
Henriksen EJ; Jacob S
Metabolism; 1995 Feb; 44(2):267-72. PubMed ID: 7869926
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Chen S; Kashiwabara H; Kosegawa I; Ishii J; Katayama S
Clin Exp Hypertens; 1996 Jul; 18(5):625-36. PubMed ID: 8781750
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid reduces visceral and ectopic lipid accumulation and insulin resistance in chronic severe hypertriacylglycerolemia.
Malinska H; Hüttl M; Oliyarnyk O; Bratova M; Kazdova L
Nutrition; 2015; 31(7-8):1045-51. PubMed ID: 26059381
[TBL] [Abstract][Full Text] [Related]
15. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
16. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism.
Henriksen EJ; Jacob S; Augustin HJ; Dietze GJ
Diabetes; 1996 Jan; 45 Suppl 1():S125-8. PubMed ID: 8529793
[TBL] [Abstract][Full Text] [Related]
17. Long-term pioglitazone treatment enhances lipolysis in rat adipose tissue.
Pravenec M; Kazdová L; Maxová M; Zídek V; Mlejnek P; Simáková M; Kurtz TW
Int J Obes (Lond); 2008 Dec; 32(12):1848-53. PubMed ID: 18936763
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro.
Leighton B; Sanderson AL; Young ME; Radda GK; Boehm EA; Clark JF
Diabetes; 1996 Jan; 45 Suppl 1():S120-4. PubMed ID: 8529792
[TBL] [Abstract][Full Text] [Related]
19. Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.
Simko F; Pelouch V; Torok J; Luptak I; Matuskova J; Pechanova O; Babal P
J Biomed Sci; 2005; 12(1):103-11. PubMed ID: 15864743
[TBL] [Abstract][Full Text] [Related]
20. Carnitine supplementation alleviates lipid metabolism derangements and protects against oxidative stress in non-obese hereditary hypertriglyceridemic rats.
Cahova M; Chrastina P; Hansikova H; Drahota Z; Trnovska J; Skop V; Spacilova J; Malinska H; Oliyarnyk O; Papackova Z; Palenickova E; Kazdova L
Appl Physiol Nutr Metab; 2015 Mar; 40(3):280-91. PubMed ID: 25723909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
